BioCentury
ARTICLE | Company News

Norgine, SpePharm deal

December 24, 2012 8:00 AM UTC

The companies created a 50/50 JV, SpePharm AG, to commercialize SpePharm Holding's entire product profile through Norgine's commercial infrastructure. The products include Dantrium dantrolene, a sodiu...